Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
16.08
-0.49 (-2.96%)
Jun 5, 2026, 12:53 PM EDT - Market open
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of $1.78 billion as of June 5, 2026. Its market cap has increased by 57.47% in one year.
Market Cap
1.78B
Enterprise Value
1.12B
1-Year Change
57.47%
Ranking
Category
Stock Price
$16.08
Market Cap Chart
Since June 18, 2014, Viridian Therapeutics's market cap has increased from $34.70M to $1.78B, an increase of 5,017.23%. That is a compound annual growth rate of 38.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 1.71B | -42.50% |
| Dec 31, 2025 | 2.97B | 95.60% |
| Dec 31, 2024 | 1.52B | 32.59% |
| Dec 29, 2023 | 1.15B | -2.59% |
| Dec 30, 2022 | 1.18B | 173.74% |
| Dec 31, 2021 | 429.50M | 567.96% |
| Dec 31, 2020 | 64.30M | 320.26% |
| Dec 31, 2019 | 15.30M | -83.62% |
| Dec 31, 2018 | 93.40M | -59.86% |
| Dec 29, 2017 | 232.70M | 6,363.89% |
| Dec 30, 2016 | 3.60M | -55.00% |
| Dec 31, 2015 | 8.00M | -16.67% |
| Dec 31, 2014 | 9.60M | -72.33% |
| Jun 18, 2014 | 34.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harmony Biosciences Holdings | 1.86B |
| Recursion Pharmaceuticals | 1.84B |
| Stoke Therapeutics | 1.83B |
| Ocular Therapeutix | 1.83B |
| Intellia Therapeutics | 1.82B |
| ADMA Biologics | 1.80B |
| Lakefront Biotherapeutics NV | 1.79B |
| Zymeworks | 1.78B |